Cargando…
Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug
Lung cancer (LC) is one of the leading causes of high cancer-associated mortality worldwide. Non-small cell lung cancer (NSCLC) is the most common type of LC. The mechanisms of NSCLC evolution involve the alterations of multiple complex signaling pathways. Even with advances in biological understand...
Autores principales: | Li, Wenqiang, Li, Mei, Huang, Qian, He, Xiaoyu, Shen, Chen, Hou, Xiaoming, Xue, Fulai, Deng, Zhiping, Luo, Yao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512551/ https://www.ncbi.nlm.nih.gov/pubmed/37744063 http://dx.doi.org/10.3389/fchem.2023.1251986 |
Ejemplares similares
-
Tumor microenvironment-oriented adaptive nanodrugs based on peptide self-assembly
por: Li, Shukun, et al.
Publicado: (2020) -
Advance Progress in Assembly Mechanisms of Carrier-Free Nanodrugs for Cancer Treatment
por: Zhang, Xiaoyu, et al.
Publicado: (2023) -
Biomimetic Red Blood Cell Membrane-Mediated Nanodrugs Loading Ursolic Acid for Targeting NSCLC Therapy
por: Wu, Ting, et al.
Publicado: (2022) -
Dual-stimuli-responsive TiO(x)/DOX nanodrug system for lung cancer synergistic therapy
por: Dai, Zideng, et al.
Publicado: (2018) -
Nanodrugs: pharmacokinetics and safety
por: Onoue, Satomi, et al.
Publicado: (2014)